Brief: PLx Pharma Inc. Reports Third Quarter 2022 Results And Provides Business Update
10/11/2022 22:23
Nov 10 (Reuters) - PLx Pharma Inc PLXP.O :
* PLX PHARMA INC Q3 SALES $400,000
* PLX PHARMA INC. REPORTS THIRD QUARTER 2022 RESULTS AND
PROVIDES
BUSINESS UPDATE
* PLX PHARMA INC Q3 ADJUSTED NON-GAAP LOSS PER SHARE $0.37
* PLX PHARMA INC Q3 GAAP LOSS PER SHARE $0.30
Source text for Eikon: ID:nGNXmF5bb
Further company coverage: PLXP.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on PLx Pharma Winddown
See all newsAustralia's Pilbara Minerals jumps on Pilgangoora lithium resource upgrade
Brief: Plx Pharma Winddown Terminated Employment Of Natasha Giordano, President And CEO, And Rita O'connor, CFO
Brief: PLx Pharma Inc. Enters Into A Stalking Horse Asset Purchase Agreement To Sell Vazalore And Substantially All Of Its Assets
U.S. STOCKS ON THE MOVE-HeartCore, Freight Technologies, MongoDB
Brief: Plx Pharma Inc. Receives Nasdaq Delisting Notice